688046 药康生物
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资90,65813.26%80,04369,19868,53630,077
投资性房地产0--0000
固定资产470,114-4.69%493,222486,699194,079175,959
在建工程118,65530.60%90,85289,603171,67053,015
无形资产49,0450.00%49,04647,34148,51449,535
商誉0--0000
其他非流动资产310,265107.25%149,709227,226303,90738,898
1,038,73720.38%862,871920,067786,706347,483

流动资产
货币资金304,334-56.61%701,372560,166421,708293,517
应收账款426,69621.63%350,806269,390185,216118,571
存货69,47428.19%54,19747,09249,47130,084
其他流动资产990,81464.21%603,399780,875810,616264,754
1,791,3194.77%1,709,7741,657,5231,467,010706,926

流动负债
短期借款255,366190.06%88,04076,15712,2065,153
应付票据0--0000
应付帐款67,684-6.22%72,175101,86050,78761,730
其他流动负债219,5134.04%210,980188,392151,077124,852
542,56346.17%371,196366,409214,070191,735
流动资产净值1,248,756-6.71%1,338,5781,291,1141,252,940515,191
资产总额减流动负债2,287,4933.91%2,201,4502,211,1812,039,647862,674

非流动负债
长期借款0--00020,027
应付债券0--0000
其他非流动负债86,44729.56%66,72386,52461,93357,014
86,44729.56%66,72386,52461,93377,041

总权益
    实收股本410,0000.00%410,000410,000410,000360,000
    储备项目1,791,0463.85%1,724,7261,714,6561,567,714425,633
股东权益2,201,0463.11%2,134,7262,124,6561,977,714785,633
非控股权益0--0000